Dengue fever is a disease spread by mosquito's bite. Dengue fever is marked by the presence of thrombocytopenia. Traditional crops such as guava are commonly used to treat dengue fever. This research aims to know the effect of guava extract administration towards megakaryocytes amount in mice femur. The study was conducted at the Laboratory of Pharmacology and Therapy, Histology Laboratory of Faculty of Medicine at Universitas Padjadjaran, Eijkman, Bandung from September until November 2016 using laboratory experimental study design. 20 Swiss webster mice strains were divided randomly into 4 groups. Group I and II were administered quinine 2.8 mg/20 grBW/day for 14 days to decrease amount of trombocytes. Group II and III were administered guava extract 0.785 mg/20 grBW/day for 5 days. Group IV was administered aquadest for 19 days. In the 27 th day, the mice left femurs were collected and made into paraffin section preparations with hematoxylin-eosin staining and then observed under microscope. Group IV had the most megakaryocytes followed by Group II, III, and I. Based on Kruskal-Wallis test, a significant difference was shown (p<0.05). MannWhitney test showed that there were significant differences between Group I and Group II, III, and IV. Meanwhile there was no significant difference between normal mice and extract-given mice. Guava extract is proven statistically significant to increase the megakaryocytes amount in thrombocytopenic mice without increasing number of megakaryocytes in normal mice. Jumlah megakariosit terbanyak adalah pada Kelompok IV diikuti dengan II, III dan I. Berdasarkan uji Kruskal-Wallis, terdapat perbedaan bermakna (p<0,05) dilanjutkan uji Mann-Whitney yaitu terdapat perbedaan bermakna antara Kelompok I dengan II, III, dan IV, sedangkan perbandingan pada kelompok mencit normal dengan kelompok yang diberi ekstrak tidak terdapat perbedaan yang bermakna. Ekstrak jambu biji dapat meningkatkan jumlah megakariosit pada mencit yang mengalami trombositopenia dan tidak menyebabkan peningkatan jumlah megakariosit secara bermakna pada mencit normal.
Introduction
Dengue fever is a disease caused by dengue virus which could be transmitted by the Aedes (Ae) mosquito's bite especially Ae. aegypti as the main vectors. 1 About 50 million cases of dengue fever occur every year and based on the data according to World Health Organization (WHO), the incidence rate in 2007 reached 150,000 cases and mostly occured in Jakarta and West Java. 2 Dengue fever could be characterized by one of the laboratory results in the form of a decrease in platelet count <150,000 cells/mm 3 called thrombocytopenia. 3 Platelets are formed from the cytoplasm of megakaryocytes (MKs), their precursor cells, which reside in the bone marrow. Their generation is a 2-stage process entailing the differentiation of hematopoietic stem cells into mature megakaryocytes and release of platelets from MKs. There are many cytokines involved in platelets generation such as SCF, GM-CSF, TPO, IL-3, IL-6 and IL-1. Psidium guajava L. known as guava is a local fruit belonging to the family Myrtaceae.
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Guava is a well-known traditional plant used to treat dengue fever. 6 The guava fruit contains vitamin C, vitamin A, iron, calcium, manganese, phosphorus, oxalate, and malic acid, morin-3-Oα-L-lyxopyranoside, morin-3-O-α-L-arabopyranoside, combinations of saponin and oleanolic acid, flavonoids, quercetin, and guaijavarin.
Based on Wiyasihati and Soegijanto's research, the extract of guava leaf was proven to increase interleukin (IL)-3 and granulocyte macrophage colony-stimulating factor (GM-CSF) thereby improving megakaryopoiesis process. Therefore, it could increase platelets in the dengue fever patients. 1, 7 According to a study by Andrianto, the guava juice proved to have significant effect on platelet counts. 8 There had been no research on the effects of guava fruits extract, consequently, the researchers wanted to know whether there is any effect of guava extract to the production of megakaryocytes as precursors of platelets in the femur of normal mice and mice induced thrombocytopenia using quinine. This study aims to determine the effects of the extract of guava on megakaryocyte amount in mice femur.
Methods
The study was conducted at the Laboratory of Pharmacology and Therapy, Histology Laboratory of Faculty of Medicine at Universitas Padjadjaran, Eijkman, Bandung from September until November 2016 using laboratory experimental study design.
Guava extraction
Fresh guava fruits were collected from a farmland located in Dukuh Waluh village, Purwokerto, Central Java, Indonesia. Guava extract was obtained and extracted using ethanol at Research Laboratory of Department of Chemistry, Universitas Padjadjaran, Singaperbangsa, Bandung. The extraction was made by cutting the guava fruits into small pieces, thereafter they were heated and dried in the oven. The dried guava pieces were then blended with 70% ethanol and underwent maceration process. 9 Animal treatment The research objects were male mice (Mus musculus), Swiss webster strain as much as 20 mice, aged 8-12 weeks, weighing 20-30 grams that had been previously been adapted for 7 days before being treated. This research was conducted by observing 3R (Reduction, Replacement, Refinement) aspects. The number of the required research objects was determined using resource equation method. clearance: 011606060).
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The inclusion criteria for this study was the mice must be healthy marked by the absence of wound, its hair was clean, and moving actively. Some of the mice were excluded because they were sick or their body weight reduced more than 10% after adaptation.
The mice were randomly divided into four groups, with five mice in each group. Group I and Group II was given quinine as much as 2.8 mg/20 grBW/day per oral for 14 days from day 8 through day 21. Then the guava extract was given as much as 0.785 mg/20 grBW/day per oral for 5 days for Group II and Group III on day 22 until day 26. Group III was given distilled water on day 8 until day 21, and Group IV as a normal group was given distilled water only on day 8 until day 26 ( Figure 1 ).
Quinine dose given to mice were obtained from a previous study by Andrianto et al., which was 100 mg/kg/day for 14 days against mice. 8 So this study used dose of quinine that has been converted into mice with a conversion value of 0.14 which was 2.8 mg/20 grBW/day for 14 days.
The guava extract dose used in this study was adopted from a previous study on the treatment of dengue fever by Harjono who explained that supplementation of guava leaf extract as much as two capsules 500 mg. Each capsule contains 2.655 mg given quercetin. 7 The dose of quercetin converted into mice with a 0.0026 conversion values was 0.0193 mg/20 grBB mice. The guava extract was known to contain quercetin according to previous research by Soegijanto et al., namely 2.46% or 2.46 mg/100 mg of extract. 7 Finally, we got the dose to extract of guava: 0.785 mg/20 grBB/day to mice.
Histological analysis
On day 27, the mice were anaesthetized using a combination of ketamine and xylazine intraperitoneally with doses 0.1 mL/20 grBB. After anesthesia worked, part of the left femur of the mice were taken and inserted into formalin as a transport medium. Then mice femur made as a paraffin section preparation that stained with hematoxylin-eosin.
The preparation was observed under microscope with 10x and 40x magnification quantitatively by counting megakaryocytes femur of 3 samples each sample preparation and each seen three visual field. The result of the calculation in units of the amount of megakaryocytes in this study was the number of megakaryocytes/low power field (LPF).
Statistical analysis
Data were calculated and analyzed using One-Way Anova. This test was a parametric 
Results
After the mice were sacrificed, mice femurs were taken and made as paraffin section preparations. Subsequently, they were observed under microscope and megakaryocytes counted using preparations overview of each of the visual field ( Figure  2 ). Based on statistical data analysis, the highest average number of megakaryocytes was in Group IV, followed by Group II, III, and I ( Figure 3 ). This test used the Shapiro-Wilk normality then conducted in order to indicated the p of Group I (quinine) = 0.678, p of Group II (quinine + guava extract) = 0.579, p of Group III (distilled water + guava extract) = 0.097, and p of Group IV (distilled water) = 0.003, therefore the data was not normally distributed with the value of p of <0.05. The homogeneity test results using Levene test showed the value of p=0.325, it means the data had a homogeneous variance value p> 0.05. The homogeneity test was followed by data analysis using the Kruskal-Wallis test which resulted significant difference between Group I and Group II, III and IV (p <0.05). Hence, according to these results, it could be concluded that the administration of guava extract could increase the number of megakaryocytes. Meanwhile, between the group of normal mice, Group II and Group III did not show any significant differences (p >0.05) ( Table 1) .
Discussion
Post-quinine administration of 2.8 mg/ 20 grBB/day dose orally for 14 days resulted the average of 16.80 cell/LPF of megakaryocytes. Comparison between the results in each group showed that the average
Figure 2 Bone Marrow of Mice Femur
After guava extract treatment, mice were sacrificed and femur was collected for HE staining. Quantitative observation of megakaryocytes in the bone marrow showed that number of megakaryocytes in Group I (A) is significantly different compared to Group II (B). Furthermore, there is no statistically difference between Group II and Group III (C) or Group IV (D). Microscopic image of 10x magnification and M is megakaryocyte. The combination of 2.8 mg/20 grBW/ day quinine orally for 14 days and 0.785 mg/20 grBW/day guava extract for 5 days generated an increase in the average number of megakaryocytes compared to the group who were given quinine only.
13,14 Guava contains vitamin C, vitamin A, iron, calcium, manganese, phosphorus, oxalate and malic acid, morin-3-Oα-L-lyxopyranoside, morin-3-O-α-L-arabopyranoside, combinations of saponin and oleanolic acid, flavonoids, quercetin, and guaijavarin. ), it is stated that the content of quercetin in guava could increase the number of megakaryocytes and thrombocytes. 1, 7, 8, 15 Quercetin was known to stimulate hematopoietic stem cells production as a precursor of the formation of mice blood. 15 Administration of quercetin in mice could make the expression of mRNA of stem cells factor (SCF), GM-CSF, and erythropoietin (Epo) in bone marrow stromal cells increase. Moreover, quercetin cytokines could stimulate hematopoiesis in bone marrow stroma in order to promote the differentiation of hematopoietic stem cells (HSC). HSC subsequently transformed into myeloid stem cells with the help of some factors such as IL-1, IL-6, and IL-3. Thereafter, it would be converted into colony forming units-granulocyte, erythroid, monocyte macrophage, megakaryocyte (CFU-GEMM) with the help of a factor GM-CSF and IL-3. Research conducted by Soegijanto et al. mentioned that quercetin might increase GM-CSF and IL-3 to accelerate the process of megakaryocytes formation. CFU-GEMM would be converted into precursors of megakaryocytes which was colony forming unit-megakaryocyte (CFU-meg), and then converted into megakaryoblast with the help of GM-CSF and IL-3. Megakaryoblast was then converted into megakaryocytes with the help of thrombopoietin. Therefore, guava extract administration was assumed to increase the number of platelets in patients with dengue fever which was the result of increasing the number of megakaryocytes. 7 Hereafter, the normal group and the group which were given guava extract showed no significant difference. These results indicated that administration of guava extract could not increase megakaryocytes or platelets in mice with normal circumstances. This proved that the quercetin component in guava did not affect the homeostasis in the form of megakaryocytes formation. Megakaryocyte formation was influenced by the presence of thrombopoietin in blood circulation. This thrombopoietin receptor binds to c-MPL on megakaryocytes to stimulate the formation of megakaryocytes. In the state of thrombocytopenia, thrombopoietin levels in circulation increased, so it bound to c-MPL to help improve megakaryocytes. Meanwhile, in normal circumstances, the platelet count was within normal limits. These platelets would then bind to circulatory thrombopoietin and did not increase megakaryocyte production. 16 So it could be assumed that the administration of guava extract could not increase the number of megakaryocytes or platelets in normal individuals as quercetin only affects factors which stimulate the formation of megakaryocytes but not affect the levels of thrombopoietin.
Limitation of this study was unknown dose of quercetin content in guava extract given to the treated group. The unknown molecular mechanism of quercetin in guava associated with formation of megakaryocytes and this study did not use a variable dose, so it cannot determine the most effective dose in order to increase the number of megakaryocytes.
Suggestion for the future research is to conduct research to provide a dose of guava extract varied with quercetin level test beforehand. Furthermore, to know the mechanism of quercetin in guava, further research is needed to determine the molecular pathway effects of quercetin.
Conclusions
Administration of guava extract at doses of 0.785mg/20 grBB/day was statistically proven to increase the number of megakaryocytes in mice that experienced thrombocytopenia. Meanwhile, in normal mice, the extract of guava could not significantly increase the number of megakaryocytes.
